1st Quarter - Report

RED+BLUE STRATEGIES for GENEDX, LLC

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —
KATHRYN WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4709 (119th)

Medicare/Medicaid MMM

Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —
KATHRYN WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7118 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.